As on Thursday, Adaptive Biotechnologies Corp (NASDAQ: ADPT) got off with the flyer as it spiked 8.48% to $19.06, before settling in for the price of $17.57 at the close. Taking a more long-term approach, ADPT posted a 52-week range of $6.26-$20.76.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -1.51%. Meanwhile, its Annual Earning per share during the time was -1.51%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 54.77%. This publicly-traded company’s shares outstanding now amounts to $152.58 million, simultaneously with a float of $146.91 million. The organization now has a market capitalization sitting at $2.91 billion.
Adaptive Biotechnologies Corp (ADPT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Adaptive Biotechnologies Corp’s current insider ownership accounts for 3.77%, in contrast to 94.07% institutional ownership. According to the most recent insider trade that took place on Jan 12 ’26, this organization’s Chief People Officer sold 79,590 shares at the rate of 17.73, making the entire transaction reach 1,411,131 in total value, affecting insider ownership by 315,978. Preceding that transaction, on Jan 12 ’26, Company’s Chief Financial Officer sold 4,290 for 18.00, making the whole transaction’s value amount to 77,220. This particular insider is now the holder of 216,637 in total.
Adaptive Biotechnologies Corp (ADPT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
Adaptive Biotechnologies Corp’s EPS increase for this current 12-month fiscal period is 54.77% and is forecasted to reach -0.59 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 29.58% through the next 5 years, which can be compared against the -1.51% growth it accomplished over the previous five years trading on the market.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Let’s observe the current performance indicators for Adaptive Biotechnologies Corp (ADPT). It’s Quick Ratio in the last reported quarter now stands at 3.26. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.51.
In the same vein, ADPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.54, a figure that is expected to reach -0.18 in the next quarter, and analysts are predicting that it will be -0.59 at the market close of one year from today.
